Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
Nayab Tahir,1–3 Asadullah Madni,2 Alexandra Correia,3 Mubashar Rehman,4 Vimalkumar Balasubramanian,3 Muhammad Muzamil Khan,2 Hélder A Santos3,51College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, The Islamia University of Bahawalpur, Bahawal...
Guardado en:
Autores principales: | Tahir N, Madni A, Correia A, Rehman M, Balasubramanian V, Khan MM, Santos HA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cba59940617b4730b2b16c2c36ffc50a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
por: Tahir N, et al.
Publicado: (2020) -
MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
por: Wu B, et al.
Publicado: (2017) -
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
por: Mukherjee A, et al.
Publicado: (2019) -
Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells
por: Yuan Y, et al.
Publicado: (2019) -
Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release
por: Men W, et al.
Publicado: (2019)